Clinical trial
Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients With…
NCT00004495 · Georgetown University, Other · Completed
Key facts
| NCT number | NCT00004495 |
|---|---|
| Title | Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients With End Stage Renal Disease Receiving Hemodialysis |
| Lead sponsor | Georgetown University, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | End Stage Renal Disease, Hyperhomocysteinemia |
| Intervention type | Drug |
| Interventions | cyanocobalamin, folic acid, pyridoxine |
| Enrollment | 84 |
| Start date | Jun 1, 1999 |
| Completion | Sep 1, 2000 |
| First posted | Oct 19, 1999 |
| Last update posted | Mar 25, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: